Clinical Trial: LETROZOLE EXTENDED VS TRADITIONAL THERAPY FOR OVULATION INDUCTION IN WOMEN WITH PCOS: A RANDOMIZED CONTROLLED TRIAL

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159880) titled 'LETROZOLE EXTENDED VS TRADITIONAL THERAPY FOR OVULATION INDUCTION IN WOMEN WITH PCOS: A RANDOMIZED CONTROLLED TRIAL' on Aug. 29.

Brief Summary: This randomized clinical trial aims to compare the efficacy and safety of extended letrozole therapy (5 mg/day for 10 days) versus standard letrozole therapy (5 mg/day for 5 days) for ovulation induction in women with polycystic ovary syndrome (PCOS). A total of 84 women aged 18-40 years will be randomized into two groups. Ovulation will be monitored by transvaginal ultrasound and confirmed with urinary LH testing and/or corpus luteum presence. The primary outcome is ovulation rate, while se...